GlassScriptPhysician profile
Heather M Jones
NPI 1164885448
$2,337.99
in general payments reported to CMS, 2019-2025
18 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $416 · 2022: $738 · 2023: $806 · 2024: $221 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $348.76 | 2022-2023 | |
| Glaxosmithkline, LLC. | $284.21 | 2021-2022 | |
| Abbvie INC. | $260.05 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $220.53 | 2021-2022 | |
| Amgen INC. | $200.26 | 2023 | Repatha, Otezla |
| Cordis US Corp. | $164.84 | 2023 | S.M.A.R.T. |
| Catalyst Pharmaceuticals, INC. | $121.08 | 2022 | |
| Sage Therapeutics, LLC | $120.00 | 2023 | |
| Madrigal Pharmaceuticals | $107.19 | 2025 | Rezdiffra |
| Alnylam Pharmaceuticals INC. | $97.31 | 2024 | Givlaari |
| Novo Nordisk INC | $93.52 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $82.77 | 2021 | |
| Sumitomo Pharma America, INC. | $72.26 | 2023 | Gemtesa |
| Abbott Laboratories | $70.38 | 2021-2022 | |
| Veryan Medical Incorporated | $48.69 | 2023 | Biomimics 3d Vascular Stent System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $15.89 | 2025 | Quikclot |
| Exact Sciences Corporation | $15.80 | 2025 | Cologuard Collection Kit |
| Eisai INC. | $14.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.